Traditional Chinese medicine in HIV cure

15 Feb 2017

1

A special issue on progress toward a cure for HIV includes a description of a previously unreported study started in the early 2000s that describes AIDS patients, currently aged between 51 and 67, being in good health.

These nine individuals were treated with a unique formula of traditional Chinese herbal medicine (TCM) from 2001-2006 or longer, with or without occasional antiviral therapy added later.

The fact that the patients currently have low or undetectable HIV in their systems is unexpected and intriguing, and suggests a potential promise of TCM as a functional cure for HIV / AIDS, as discussed in a "Letter to the Editor" in the special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

The Letter to the Editor is available open access on the AIDS Research and Human Retroviruses website.

In Long-Term Survival of AIDS Patients Treated with Only Traditional Chinese Medicine, Yifei Wang, Fujun Jin, Qiaoli Wang, and Zucai Suo, Jinan University (Guangdong, China) and The Ohio State University (Columbus), report that most of the individuals in this small study have undetectable viral loads, with one patient having a low viral load. Their CD4+ counts and CD4+/CD8+ ratios are all excellent.

In an accompanying Editorial titled Can a Traditional Chinese Medicine Contribute to a Cure for HIV? Thomas Hope, PhD, editor-in-chief of AIDS Research and Human Retroviruses and Professor of Cell and Molecular Biology at Northwestern University, Feinberg School of Medicine (Chicago, IL), while pointing out the limitations in interpreting the outcome of this small, non-placebo-controlled study, comments on the importance of putting "these observations into the hands of the HIV research community." He writes, "I believe there should be some effort to further explore this phenomenon."

Both the Letter to the Editor and Editorial are part of a new Special Issue on HIV Cure Research published in AIDS Research and Human Retroviruses.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round